Freenome, Inc. - Common stock (FRNM)

10.91
-0.10 (-0.91%)
NASDAQ· Last Trade: Aug 5th, 3:43 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close11.01
Open11.20
Bid10.85
Ask11.17
Day's Range10.71 - 11.43
52 Week Range9.970 - 14.26
Volume600,045
Market Cap-
PE Ratio (TTM)-
EPS (TTM)-
Dividend & YieldN/A (N/A)
1 Month Average Volume784,383

Chart

News & Press Releases

FDA Approves Freenome’s SimpleScreen™ CRC Blood-Based Screening Test; Abbott to Commercialize in the U.S.
– Approval expands colorectal cancer screening options for the up to 60 million Americans who are overdue for screening –
By Freenome, Inc. · Via GlobeNewswire · July 27, 2026